CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishDefining the severity of ARDS using PaO2/FIO2 , 150 as a surrogate for life-threatening edema is a promising approach. However, ARDS is a heterogeneous syndrome, and identifying a treatment-responsive hyperinflammatory subtype across the PaO2/FIO2 severity spectrum suggests the fundamental limitations of using physiological or anatomic variables alone to understand and treat the underlying mechanisms that lead to ARDS, let alone to stratify risk. We suspect that both approaches will be complementary and will require prospective evaluation for their predictive enrichment potential
| Titolo: | Assessing risk and treatment responsiveness in ARDS: Beyond Physiology | |
| Autore/i: | Sorbo, Lorenzo Del; Nava, Stefano; Rubenfeld, Gordon; Thompson, Taylor; Marco Ranieri, V. | |
| Autore/i Unibo: | ||
| Anno: | 2018 | |
| Rivista: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1164/rccm.201802-0273ED | |
| Abstract: | Defining the severity of ARDS using PaO2/FIO2 , 150 as a surrogate for life-threatening edema is a promising approach. However, ARDS is a heterogeneous syndrome, and identifying a treatment-responsive hyperinflammatory subtype across the PaO2/FIO2 severity spectrum suggests the fundamental limitations of using physiological or anatomic variables alone to understand and treat the underlying mechanisms that lead to ARDS, let alone to stratify risk. We suspect that both approaches will be complementary and will require prospective evaluation for their predictive enrichment potential | |
| Data stato definitivo: | 2018-11-09T11:31:02Z | |
| Appare nelle tipologie: |
File in questo prodotto:
Copyright © 2022